bit.bio, the company coding human cells for novel cures, announced its cell therapy pipeline and declared its lead cell therapy candidate as it prepares to...
To help life sciences companies create sustainable value and drive growth, Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud...
Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, announced the commercial release of its BioXp® De novo Cloning and Amplification...
QIAGEN and Element Biosciences, Inc. announced a strategic partnership to offer comprehensive next-generation sequencing (NGS) workflows for the Element AVITI™ System, an innovative sequencing...
New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatment.
GE HealthCare’s Artificial Intelligence...
Medidata to announce latest innovations to accelerate drug and device development to bring treatments to patients sooner
Medidata, a Dassault Systèmes company and leading provider...
Multi-year collaboration will enable development of complex, cutting-edge cell therapies and armoring technologies for solid tumor targets
Generate:Biomedicines and Roswell Park Comprehensive Cancer Center announced...